ILD & Early Rheumatoid Arthritis
Trial Objectives
The purpose of this study is to learn how interstitial lung disease (ILD) develops and progresses over time in people with early rheumatoid arthritis (RA). There is evidence that RA starts in the lungs in a subset of patients and through this study researchers will be looking at the relationship between your RA and your lungs.
Who Can Participate
Adults diagnosed with rheumatoid arthritis within the last two years may be eligible to participate.
Age: 18-90 Gender: Any
Estimated Time Commitment
5 in-person visits over 18 months
Payment & Reimbursement
Payment: Not Provided
Travel Reimbursement: Not Available
Trial Location
National Jewish Main Campus, Denver, CO
Trial Sponsors
Boehringer Ingelheim
Principal Investigators
Joshua J. Solomon, MD
Co-Investigators
Michael P. Mohning, MD